Alopecia areata (AA) is an organ-specific autoimmune disorder that targets anagen phase hair follicles. The course is unpredictable and current available treatments have variable efficacy. Nowadays, there is relatively little evidence on treatment of AA from well-designed clinical trials. Moreover, none of the treatments or devices commonly used to treat AA are specifically approved by the Food and Drug Administration. The Italian Study Group for Cutaneous Annexial Disease of the Italian Society of dermatology proposes these Italian guidelines for diagnosis and treatment of Alopecia Areata deeming useful for the daily management of the disease. This article summarizes evidence-based treatment associated with expert-based recommendations.
Italian guidelines in diagnosis and treatment of alopecia areata / Rossi, A.; Muscianese, M.; Piraccini, B. M.; Starace, M.; Carlesimo, M.; Mandel, V. D.; Alessandrini, A.; Calvieri, S.; Caro, G.; D'Arino, A.; Federico, A.; Magri, F.; Pigliacelli, F.; Amendolagine, G.; Annunziata, M. C.; Arisi, M. C.; Astorino, S.; Babino, G.; Bardazzi, F.; Barruscotti, S.; Belloni Fortina, A.; Borghi, A.; Bruni, F.; Caccavale, S.; Calzavara-Pinton, P.; Cameli, N.; Cardone, M.; Carugno, A.; Coppola, R.; Dattola, A.; De Felici Del Giudice, M. B.; Di Cesare, A.; Dika, E.; Dinunno, D.; D'Ovidio, R.; Fabbrocini, G.; Feliciani, C.; Fulgione, E.; Galluzzo, M.; Garcovich, S.; Garelli, V.; Guerriero, C.; Hansel, K.; La Placa, M.; Lacarrubba, F.; Lora, V.; Marinello, E.; Megna, M.; Micali, G.; Misciali, C.; Monari, P.; Monfrecola, G.; Neri, I.; Offidani, A.; Orlando, G.; Papini, M.; Patrizi, A.; Piaserico, S.; Rivetti, N.; Simonetti, O.; Stan, T. R.; Stingeni, L.; Talamonti, M.; Tassone, F.; Villa, L.; Vincenzi, C.; Fortuna, M. C.. - In: GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA. - ISSN 0392-0488. - ELETTRONICO. - 154:6(2019), pp. 609-623. [10.23736/S0392-0488.19.06458-7]
Italian guidelines in diagnosis and treatment of alopecia areata
Federico A.;Amendolagine G.;Borghi A.;Bruni F.;Coppola R.;Megna M.;Offidani A.;Simonetti O.Membro del Collaboration Group
;Talamonti M.;Vincenzi C.Membro del Collaboration Group
;
2019-01-01
Abstract
Alopecia areata (AA) is an organ-specific autoimmune disorder that targets anagen phase hair follicles. The course is unpredictable and current available treatments have variable efficacy. Nowadays, there is relatively little evidence on treatment of AA from well-designed clinical trials. Moreover, none of the treatments or devices commonly used to treat AA are specifically approved by the Food and Drug Administration. The Italian Study Group for Cutaneous Annexial Disease of the Italian Society of dermatology proposes these Italian guidelines for diagnosis and treatment of Alopecia Areata deeming useful for the daily management of the disease. This article summarizes evidence-based treatment associated with expert-based recommendations.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
